-
Biogen Inc. is an
American multinational biotechnology company based in Cambridge, M****achusetts,
United States specializing in the discovery, development...
-
people with Alzheimer's
disease to
reduce its buildup. It was
developed by
Biogen and Eisai.
Aducanumab is
given via
intravenous infusion.
Aducanumab was...
-
Biogen (UK) Ltd is a
leading UK
owner and
operator of
anaerobic digestion and
composting plants based in Bedfordshire. It is
responsible for the construction...
- as CEO
between 2021 and 2022. He was
formerly the
president and CEO of
Biogen Idec
until he
retired effective June 8, 2010. At the same time, he started...
-
funded by Cure SMA.
Starting in 2012,
Ionis partnered with
Biogen on
development and, in 2015,
Biogen acquired an
exclusive license to the drug for a US$75...
- T-cells. In
March 2018, it was
voluntarily withdrawn from the
market by
Biogen and
Abbvie after reports of
autoimmune encephalitis in Europe. Daclizumab...
- S2CID 46326042. "
Biogen Idec's TECFIDERA™ (Dimethyl Fumarate)
Approved in US as a First-Line Oral
Treatment for
Multiple Sclerosis" (Press release).
Biogen Idec....
-
conducted by
Fumapharm in
collaboration with
Biogen Idec;
Fumapharm was
subsequently acquired by
Biogen Idec in 2006.
Aditech Pharma in
Sweden had also...
- esters,
primarily dimethyl fumarate, and
marketed as
Fumaderm by
Biogen Idec in Europe.
Biogen would later go on to
develop the main ester,
dimethyl fumarate...
-
Villalobos is a
medicinal chemist and
senior pharmaceutical executive at
Biogen.
Villalobos was
raised in
Panama City. She
received her BS in chemistry...
